Hormonal protection in acute pancreatitis by ghrelin, leptin and melatonin by unknown
ghrelin seems to be indirect and perhaps dependent on 
the release of growth hormone and insulin-like growth 
factor 1. Leptin and ghrelin, but not melatonin, employ 
sensory nerves in their beneficial action on acute pan-
creatitis. It is very likely that ghrelin, leptin and melato-
nin could be implicated in the natural protection of the 
pancreatic gland against inflammatory damage because 
the blood levels of these substances increase in the 
initial phase of pancreatic inflammation. The above 
hormones could be a part of the innate resistance sys-
tem which might remove noxious factors and could 
suppress or attenuate the inflammatory process in the 
pancreas.
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Core tip: The pathogenesis of acute pancreatitis is not 
clear and treatment of this disease is unspecific. Since 
the severe form of acute pancreatitis often leads to 
death or to pancreatic insufficiency, the understanding 
of the mechanisms involved in pancreatic protection 
appears to be an important problem. Experimental 
data have shown that pancreatitis severity could be at-
tenuated by various hormones. Herein, we review the 
results of our research studies and others, as well as 
data from clinical observations concerning the protec-
tive effects of ghrelin, leptin and melatonin on acute 
pancreatitis. We also present the hypothetical mecha-
nisms responsible for the beneficial influence of these 
substances on pancreatic inflammation.
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Abstract
Acute pancreatitis is a nonbacterial disease of the pan-
creas. The severe form of this ailment is characterized 
by high mortality. Whether acute pancreatitis develops 
as the severe type or resolves depends on the inten-
sity of the inflammatory process which is counteracted 
by the recruitment of innate defense mechanisms. It 
has been shown that the hormones ghrelin, leptin and 
melatonin are able to modulate the immune function 
of the organism and to protect the pancreas against 
inflammatory damage. Experimental studies have dem-
onstrated that the application of these substances prior 
to the induction of acute pancreatitis significantly at-
tenuated the intensity of the inflammation and reduced 
pancreatic tissue damage. The pancreatic protective 
mechanisms of the above hormones have been related 
to the mobilization of non-specific immune defense, to 
the inhibition of nuclear factor kappa B and modulation 
of cytokine production, to the stimulation of heat shock 
proteins and changes of apoptotic processes in the 
acinar cells, as well as to the activation of antioxidant 
system of the pancreatic tissue. The protective effect of 
WJG 20th Anniversary Special Issues (18): Pancreatitis
TOPIC HIGHLIGHT
INTRODUCTION
Acute pancreatitis is a sterile inflammatory disease of  the 
pancreatic tissue. This ailment has been classified as mild, 
moderate or severe[1]. Mild pancreatitis is the most com-
mon, local pancreatic inflammation which resolves by it-
self. Moderate or severe acute pancreatitis with organ fail-
ure requires prolonged and expensive hospitalization, is 
characterized by high mortality and often leads to endo-
crine or exocrine dysfunction of  the pancreas[2,3]. Despite 
the intensive research and clinical studies of  the last de-
cades, the pathogenesis of  acute pancreatitis still remains 
unclear and the treatment of  this disease is not specific. 
It is believed that the key determinant of  this disease is 
the intra-acinar activation of  digestive enzymes (mainly 
trypsin) and autodigestion of  the pancreatic gland which 
initiates local (mild pancreatitis) or systemic (moderate 
and severe form of  this disease) inflammation[4]. 
The cellular mechanisms responsible for zymogen 
activation are not fully understood. One possible expla-
nation could be an impaired autophagy process resulting 
from lysosomal dysfunction and imbalance between two 
lysosomal enzymes: cathepsin B, which cleaves trypsino-
gen into active trypsin, and cathepsin L, responsible for 
trypsin degradation. The abnormal function of  mito-
chondria and ATP depletion suppresses apoptosis and 
promotes acinar necrosis[5]. Damaged acinar cells release 
toxic substances, known as damage associated molecular 
patterns (DAMP), to the extracellular space leading to 
the propagation of  the sterile inflammatory process[6]. 
Another hypothesis shows that activation of  the nuclear 
NFκB, observed in the early step of  acute pancreatitis, 
could be related to the cleavage of  trypsinogen into ac-
tive trypsin. However, the relationship between these 
phenomena has not been elucidated[7]. Recently, an inter-
esting theory concerning the role of  the pancreatic duct 
cells in the pathogenesis of  acute pancreatitis has been 
presented. It has been explained that the reduction of  bi-
carbonate secretion by duct cells leads to the acidification 
of  the luminal space and contributes to the intracellular 
zymogen activation[8]. 
The inflammatory process in the pancreas is counter-
acted by activation of  innate defense systems which could 
remove injurious agents to suppress or reduce pancreatic 
inflammation. Stimulation of  the immune cells, produc-
tion of  protective substances and anti-inflammatory 
cytokines, modulation of  the apoptotic signaling pathway 
and activation of  antioxidant defense systems are among 
the mechanisms implicated in the cellular and tissue re-
sistance[9-12]. Identification of  the factors which trigger 
the defense systems against acute pancreatitis could be 
of  great importance for the creation of  new therapeutic 
strategies in this disease. 
Previous experimental studies on acute pancreatitis 
have evidenced that non-specific immunity and innate 
defense systems could be activated in several ways and 
by various factors, such as stimulation of  nitric oxide 
synthase (NOS) and generation of  nitric oxide (NO), 
thermal preconditioning and administration of  low doses 
of  biologically active substances or endotoxins[12-14]. Some 
hormones have been shown to protect the pancreas 
against the development of  acute pancreatitis and to at-
tenuate the course of  this disease. Suppression of  pan-
creatic inflammation and a marked reduction of  tissue 
inflammatory damage have been observed as the result 
of  the application of  the hormones ghrelin, leptin and 
melatonin. 
GHRELIN
Structure, tissue expression, receptors and biological 
effects 
Ghrelin, an endogenous ligand for the growth hormone 
secretagogue receptor, was originally isolated from the rat 
stomach by Kojima et al[15]. The main source of  ghrelin 
in the organisms of  rats and dogs appears to be X/A 
cells of  the oxyntic mucosa, which represent 20% of  the 
mucosal cell population, whereas in humans, ghrelin has 
been found in the P/D1 cell type[15,16]. Besides the stom-
ach, ghrelin has been widely expressed in the additional 
tissues of  the gastrointestinal tract (duodenum, jejunum, 
colon, pancreas), in the central nervous system (hypo-
thalamus, cortex, brain stem, pituitary) and in other or-
gans (kidney, heart, lung, testis, immune cells)[16-20]. In the 
pancreas, ghrelin-producing cells represent an indepen-
dent cell population of  the pancreatic islets and ghrelin is 
possibly involved in glucose homeostasis[21]. The ghrelin 
system (ghrelin and its receptor) also exists in the pancre-
atic acinar cells[22]. An experimental study has shown that 
ghrelin could be implicated in the stimulation of  pancre-
atic enzyme secretion[23]. 
Part of  ghrelin peptides undergoes posttranslational 
acylation, dependent on the enzyme ghrelin-O-acyl-
transferase (GOAT), and circulating ghrelin consists 
of  two forms: desacyl ghrelin (90%) and acyl ghrelin 
(10%)[24]. Both forms of  ghrelin are agonists of  the 
ghrelin receptor; however, under physiological condi-
tions, only acylated ghrelin is able to activate the intracel-
lular signaling cascade of  this receptor[15,25]. The desacyl 
ghrelin has previously been believed to be a degradation 
product of  acyl ghrelin but recent observations have 
shown that desacyl ghrelin is able to produce biological 
effects independent of  those of  acylated peptide. It has 
been reported that desacyl ghrelin prevented the activa-
tion of  apoptosis and fibrosis of  cardiomyocytes and 
protected endothelial cells from apoptosis induced by 
oxidative stress[26,27]. Administration of  desacyl ghrelin to 
rats modulated body temperature and produced arterial 
dilatation, probably via activation of  the parasympathetic 
nervous system[28]. On the other hand, desacyl ghrelin 
could antagonize the activation of  the acylated form. All 
these observations suggest that desacyl ghrelin might be 
a separate hormone which interacts with its own specific, 
as yet unknown, receptor[29].
The ghrelin receptor (GHS-Rs) is a G-protein coupled 
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receptor characterized by transmembrane domains[23]. 
GHS-R has been identified as two spliced variants: func-
tional ghrelin receptor type 1 (GHS-R1a) and non-func-
tional, unspliced GHS-R1b. Both GHS-R1s have been 
predominantly expressed in the pituitary but this receptor 
has also been detected in the pancreas, spleen, heart, ad-
renal and thyroid glands[30,31]. 
Ghrelin has been shown to produce a wide range of  
biological effects in the organism, such as: (1) release of  
prolactin, adrenocorticotropic and growth hormones; 
(2) control of  appetite and food intake; (3) stimulation 
of  gastric and pancreatic secretion and gastrointestinal 
motility; (4) modulation of  cardiovascular and repro-
ductive functions; (5) increase of  neoglucogenesis and 
adipogenesis; (6) stimulation of  bone formation; and (7) 
modulation of  immune functions[32]. Nevertheless, the 
physiological involvement of  ghrelin in most of  above 
functions is not completely clear. 
 
Anti-inflammatory effects of ghrelin 
The anti-inflammatory effects of  ghrelin have been 
shown in many tissues, including the pancreas[33]. Ghre-
lin protects gastric mucosa against acute ulceration and 
accelerates the healing of  chronic gastric and duodenal 
ulcers[34]. Ghrelin suppresses inflammation in sepsis and 
inflammatory bowel disease, reduces inflammatory pain 
and attenuated chronic liver injury[35-38]. The presence 
of  ghrelin receptors on human peripheral lymphocytes, 
neutrophils and on the leukemic T, B and myeloid cell 
lines indicates that ghrelin is able to directly affect the 
functions of  immune cells[20]. Indeed, ghrelin could in-
hibit production of  anti-inflammatory cytokines, such as 
tumor necrosis factor alpha (TNFα), interleukin 1β (IL-
1β), interleukin 6 (IL-6) and interleukin 8 (IL-8)[33,38-40]. It 
has been demonstrated that the downregulation of  pro-
inflammatory cytokines by ghrelin is mediated by MAPK 
phosphatase-1 enzyme involved in the innate immune 
response[41]. In addition, ghrelin has been found to reduce 
the phagocytic activity of  macrophages in vivo and in vitro 
and to decrease the production of  high mobility box 1 
protein (HMGB1)[42,43]. The anti-inflammatory effect of  
ghrelin could also be attributed to the activation of  NOS 
and to enhanced production and release of  NO[38]. Con-
troversial reports have been presented concerning the 
effect of  ghrelin on nuclear factor kappa B (NF-κB). In 
human B cells, ghrelin promotes NF-κB, whereas in the 
pancreas, ghrelin inhibits activation of  this substance[44,45].
Ghrelin and acute pancreatitis
Numerous studies have shown that administration of  
ghrelin to animals prior to the induction of  acute pan-
creatitis protected pancreatic tissue against damage and 
attenuated the inflammation[10,30,45-47]. Ghrelin reduced 
the morphological signs of  acute pancreatic inflamma-
tion, diminished blood levels of  IL-1β, decreased plasma 
lipase and improved DNA synthesis in rats subjected 
to caerulein-induced pancreatitis; however, pancreatic 
blood flow in these animals was unaffected by ghrelin[30]. 
The favorable effect of  ghrelin on the pancreas has been 
also demonstrated in acute necrotizing L-arginine pan-
creatitis as well as in taurocholate-induced pancreatitis 
and is attributed to the inhibition of  NFκ-B expression 
and the blockade of  the inflammatory signal transduc-
tion pathway[44,45]. In addition, ghrelin has been demon-
strated to lessen pancreatitis-associated lung injury, to 
reduce sequestration of  neutrophils in the lung, to limit 
production of  the proinflammatory cytokines, such as 
IL-6, and TNFα, and to inhibit pulmonary substance P 
expression[47,48]. 
Ghrelin could exert its positive effect on the pancreas 
via the central mechanism because the pancreatic protec-
tive effect of  ghrelin was observed following application 
of  this peptide into the cerebral ventricles of  rats sub-
jected to caerulein-induced pancreatitis. This protection 
was correlated with the release of  growth hormone (GH) 
and was completely reversed by deactivation of  sensory 
nerves with capsaicin[10]. Hypophysectomy cancelled out 
the pancreatic protection evoked by ghrelin and elimi-
nated GH and insulin-like growth factor 1 (IGF-1) from 
the serum[46]. The above results present the evidence that 
the protective effect of  ghrelin on the pancreas is indirect 
and depends on the activation of  sensory nerves and the 
release of  GH and IGF-1. 
A recent report has shown the therapeutic effect of  
ghrelin in the course of  caerulein-induced pancreatitis. 
Administration of  ghrelin after the development of  acute 
pancreatitis reduced the intensity of  pancreatic inflamma-
tion and accelerated the regeneration of  the gland. This 
effect was mainly related to the reduction of  IL1β and to 
the stimulation of  pancreatic cell proliferation[49].
It was demonstrated that in animals with acute pan-
creatitis, serum levels of  endogenous ghrelin at 24 and 48 
h were significantly increased compared to the control[47]. 
Clinical studies have shown that ghrelin levels measured 
at the first, third and fifth day of  hospitalization in pa-
tients with acute pancreatitis were higher than in healthy 
individuals[50]. It was also reported that serum ghrelin 
levels were markedly elevated in patients with high risk 
factors for severe forms of  acute pancreatitis[51]. It is very 
likely that ghrelin is released in high amounts in response 
to the initiation of  the inflammatory process in the pan-
creas to suppress the inflammation and protect the pan-
creatic tissue. 
All the above observations indicate that ghrelin could 
be implicated in the natural protection of  the pancreatic 
tissue through the activation of  the innate immune sys-
tem to prevent the development of  the inflammatory 
process in the pancreas. The pancreatic protective effect 
of  ghrelin appears to be indirect and depends on the re-
lease of  GH and IGF-1 by ghrelin (Figure 1). 
LEPTIN
Structure, tissue expression, receptors and biological 
effects
Leptin is one of  the adipokines, cytokine-like hormones 
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in the organism[59]. The reports concerning the effect 
of  leptin on the immune processes are contradictory. In 
some studies, leptin has been shown to trigger inflamma-
tory responses and to play an important role in chronic 
inflammation[62,63]. Other studies documented the anti-
inflammatory effects of  leptin[64,65]. 
It has been reported that leptin improved the function 
of  macrophages, modulates lymphocyte proliferation, 
increases the ratio of  T naïve/T memory cells and stimu-
lates the production of  pro-inflammatory cytokines, such 
as TNFα, IL-1 and IL-6[66]. Leptin production increases 
in acute inflammation and sepsis. It was proposed that 
leptin blood levels could be a predictive factor of  the in-
creased survival and attenuation of  inflammation[67]. Ad-
ditional evidence for the beneficial role of  leptin in sepsis 
comes from the observation that the administration of  
exogenous leptin increased survival in septic mice[68].
Leptin and acute pancreatitis
Our previous reports have demonstrated that the ap-
plication of  leptin to rats prior to the induction of  acute 
caerulein-induced pancreatitis significantly reduced the 
severity of  pancreatic inflammation[69]. This beneficial 
effect of  leptin has been observed following intraperito-
neal as well as intracerebroventricular administration of  
this adipokine. The effect of  leptin on acute pancreatitis 
was completely abolished by the deactivation of  sensory 
nerves with capsaicin. These nerves employed calcitonin 
gene-related peptide (CGRP) as one of  the neuromedia-
tors[70]. The pharmacological blockade of  sensory nerves 
which are produced in white adipose tissue. Besides 
adipocytes, leptin has been also detected in other or-
gans, such as the stomach, muscles and bones[52,53]. This 
16-kDa protein is encoded by the ob gene and was first 
recognized as an inhibitor of  appetite, a stimulator of  
energy expenditure and a regulator of  body weight[54]. 
Leptin is well known as one of  the main modulators of  
energy balance but is also implicated in the regulation 
of  neuroendocrine and secretory functions of  the body. 
Indeed, leptin has been shown to affect gastric and pan-
creatic secretions, insulin release, to protect the gastric 
mucosa against noxious agents and to influence the in-
flammatory process in the pancreas[55,56]. Leptin could be 
also involved in the modulation of  several processes of  
the body, such as reproduction, angiogenesis and bone 
metabolism, but recent studies have focused on the role 
of  leptin in immunity[57-59]. 
Leptin exerts its effect through its specific receptor 
(Ob-R) which belongs to the class I of  the cytokine fam-
ily, together with receptors for IL-6 and IL-12. Ob-R is 
represented by six isoforms of  different length but only 
full-length Ob-Rb is able to activate the signal transduc-
tion pathway[60]. Ob-R is present in the hypothalamus, pi-
tuitary, kidney, lung, bone marrow, enterocytes, reproduc-
tive system and pancreatic acinar cells, as well as all types 
of  immune cells[24,60,61]. 
Effects of leptin on immune functions
Leptin received particular attention as the main modula-
tor of  immune functions and inflammatory processes 
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Figure 1  Hypothetical mechanisms of the protective action of ghrelin, leptin and melatonin on acute pancreatitis. GH: Growth hormone; IGF-1: Insulin-like 
growth factor; NF-κB: Nuclear factor kappa B; HSP60: Heat shock protein 60; nNOS: Neural nitric oxide synthase; NO: Nitric oxide; TNFα: Tumor necrosis factor α; 
IL: Interleukin; MPO: Myeloperoxidase; SOD: Superoxide dismutase; CAT: Catalase; GPx: Glutathione peroxidase; GR: Glutathione reductase; ROS: Reactive oxygen 
species; RNS: Reactive nitrogen species.
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with CGRP 8-37, an antagonist of  CGRP, resulted in 
the total reversion of  the favorable effects of  leptin 
on acute pancreatitis[69]. This observation indicates that 
sensory nerves and CGRP play a part in the protection 
of  the pancreatic gland afforded by leptin against acute 
damage. Subsequent studies have shown that leptin treat-
ment ameliorates lung injuries in rats with the caerulein 
model of  acute pancreatitis[71]. In addition, treatment 
with leptin accelerated pancreatic tissue repair in animals 
subjected to ischemic pancreatitis[72]. The positive effects 
of  this adipokine on acute pancreatitis have been also 
observed in the model of  acute pancreatitis evoked by 
ischemia/reperfusion and documented by histological 
assessment and significant reduction of  TNFα and Il-1β 
blood levels[71,72]. The beneficial effect of  leptin on acute 
pancreatitis could be attributed to the activation of  the 
NOS/NO system and release of  NO in the pancreas, to 
the improvement of  pancreatic microcirculation and, at 
least in part, to the release of  glucocorticoids which pro-
vide an unspecific attenuation of  the inflammatory pro-
cesses[61,62,69,72] (Figure 1). A study on the pancreatic acinar 
cell line AR42J revealed that leptin is able to increase the 
gene expression of  heat shock protein 60 (HSP60) in 
these cells[73]. HSP60 belongs to the group of  chaperone 
proteins, stimulated by high temperature, oxidative stress 
or inflammation. Activation of  HSP60 by leptin could 
limit mitochondrial and nuclear injury, might prevent the 
endoplasmic reticulum from the damage and could reduce 
formation of  autophagosomes[73,74].
More evidence concerning the important role of  
leptin in acute pancreatitis comes from experiments on 
congenitally obese mice with a deficient leptin system. In 
this study, obese knockout mice with deficits of  leptin 
(LepOb mice) or leptin receptor (LepDb mice) developed 
acute pancreatitis in the more severe form than the acute 
pancreatitis demonstrated in wild-type animals[75]. This 
observation clearly shows that the leptin system is impli-
cated in the innate immune defense against acute pan-
creatic inflammation, yet leptin is not a sole player in the 
modulation of  pancreatic resistance. Other adipokines, 
such as adiponectin, visfatin and resistin, could also play a 
role in the modulation of  acute pancreatitis severity[59,76]. 
In contrast to the reports presenting the anti-inflam-
matory effects of  leptin, recent publications have shown 
that leptin up-regulated the expression of  toll-like recep-
tor 2 (TLR-2) on human monocytes and increased TNFα 
expression stimulated by endotoxins. This activity of  
leptin may potentiate innate immunity and inflammation 
in obese hyperleptinemic patients[77]. Studies on obese 
(hyperleptinemic) rats with acute necrotizing pancreatitis 
indicated that in these animals the expression of  pro-
inflammatory IL-6 was higher, whereas the signal of  anti-
inflammatory IL-10 was lower than in the group of  lean 
animals[78]. Some authors concluded that obesity and 
hyperleptinemia could be a risk factor for severe acute 
pancreatitis[76,79].
Changes of  leptin level in acute pancreatitis have 
been the subject of  numerous experimental and clinical 
studies. Many investigators have noted the considerable 
increases of  leptin blood levels in acute pancreatitis in 
rats and humans[47,64,75,80]. Nevertheless, the leptin blood 
levels did not correlate with pancreatitis severity[47,80-82]. 
The recent comprehensive review of  Karpavicius et al[83] 
analyzed the prognostic value of  leptin and other adipo-
kines in predicting the course of  acute pancreatitis. The 
authors concluded that leptin levels increase in acute pan-
creatitis; however, these levels are not in parallel with the 
severity of  acute pancreatitis and could not be used as a 
prognostic value of  the course and possible complica-
tions of  this disease[83]. 
The results of  the above studies lead to the conclu-
sion that leptin could be considered a factor which po-
tentiates non-specific immune defense and stimulates 
inflammatory reaction. It has been shown that leptin 
blood levels increase in acute pancreatitis, yet these levels 
have not been related to the severity of  this disease. It 
is very likely that leptin could activate the initial phase 
of  the innate immune response and thus trigger the im-
mune defense in the early stages of  inflammation. Such 
a mobilization of  the immune system might suppress 
the acute inflammation near the beginning and prevent 
the development of  serious disease. Nevertheless, with 
the development of  intensive inflammation, leptin could 
continuously activate the immune cells and interleukin 
production to combat the pathogens or factors respon-
sible for inflammation. Constant stimulation of  the im-
mune system by leptin might favor the progression of  an 
inflammatory state.
It is worth remembering that other adipokines besides 
leptin also participate in the modulation of  inflammatory 
process and an imbalance between leptin and other adi-
pokines could deregulate the immune response. 
MELATONIN
Structure, tissue expression and receptors 
Melatonin (5-methoxy-N-acetyltryptamine) is an indole-
amine, produced from amino acid L-tryptophan in the 
four steps reaction with serotonin as a direct melatonin 
precursor[84]. This indoleamine is released from the pineal 
gland in the regular nocturnal/diurnal rhythm, with the 
peak at night[85]. Melatonin was discovered first in the pi-
neal gland and is best known as the pineal hormone but 
this substance has also been found in numerous mamma-
lian tissues, such as the retina, Harderian gland, brain and 
in the gastrointestinal system, which appears to be the 
richest source of  melatonin in the organism[86-88]. Gastro-
intestinal melatonin originates from the enteroendocrine 
cells of  the gut mucosa, from food ingested and from 
bile[87,89,90]. Food stimulates the release of  melatonin in a 
manner independent of  the light/dark cycle[88,91].
Melatonin could exert its biological effect via its spe-
cific receptors MT1, MT2 and MT3 on the cell membranes, 
but it could also directly enter into the cell because of  its 
high solubility in lipids[92]. Melatonin membrane receptors 
MT1 and MT2 belong to 7-transmembrane G-protein-
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coupled receptors and both could be antagonized by luz-
indole[93]. Melatonin receptor MT3 is an enzyme quinone 
reductase 2 known as a potent antioxidant[93,94]. Melatonin 
could perhaps activate nuclear orphan receptors RZR/
ROR but the role of  these receptors is not known[94].
Melatonin receptors have been detected in many tis-
sues, such as the central nervous system, cardiovascular 
system, immune cells, retina and the gastrointestinal 
system[94,95]. Both melatonin and its receptors have been 
identified in the human pancreatic tissue in the islet of  
Langerhans and this indoleamine has been suggested as 
one of  the modulators of  insulin secretion[95]. 
Anti-inflammatory effects of melatonin
Melatonin has been reported to produce a wide range of  
biological effects but its physiological role in the organ-
ism is still unknown. This substance was first recognized 
as part of  the biological clock because of  its rhythmic 
diurnal/nocturnal secretions[84,96]. Subsequent studies 
have shown a very special role of  melatonin as a vitally 
important tissue protector and modulator of  immune re-
sponse. Melatonin enhances tissue defense against oxida-
tive damage because it is a potent activator of  antioxidant 
enzymes and a direct scavenger of  radical oxygen (ROS) 
and nitrogen (RNS) species. ROS and RNS are produced 
in mitochondria and under normal conditions they are 
neutralized by antioxidant enzymes as well as by natural 
non-enzymatic scavengers, such as melatonin, glutathione, 
vitamins C and E and others[97,98]. Oxidative stress and 
inflammation resulted in the massive production of  these 
free radicals which could not be counteracted by anti-
oxidant defense of  tissue, leading to tissue damage[99,100]. 
Melatonin also activates the second line of  tissue defense 
which is dependent on the antioxidant enzymes, such as 
superoxide dismutase (SOD), catalase (CAT), glutathione 
peroxidase (GPx) or glutathione reductase (GR)[101-103].
Besides its antioxidant properties, melatonin could 
strengthen the immune defense through the modulation 
of  the signal transduction pathways involved in inflam-
matory processes. Melatonin inhibits the nuclear binding 
of  NF-kappaB and in this manner it could reduce the 
production of  pro-inflammatory cytokines (TNFα and 
interleukins IL-1β, IL-6, IL-8)[104]. This indoleamine has 
been reported to reduce prostaglandin synthesis, to mod-
ulate cell apoptosis and necrosis, and to affect the process 
of  angiogenesis[105-107]. 
 
Melatonin and acute pancreatitis 
Experimental studies have shown that the administra-
tion of  melatonin to rats prior to the induction of  acute 
pancreatitis protected the pancreas from the develop-
ment of  acute inflammation and significantly diminished 
pancreatic tissue damage[108-114]. Melatonin radically re-
duced the morphological signs of  inflammation, such 
as edema, leukocyte infiltration and the vacuolization of  
the acinar cells[10,111,115-117]. The blood levels of  amylase 
and lipase, the indicator enzymes of  acute pancreatitis 
severity, as well as blood levels of  pro-inflammatory cy-
tokine TNFα, were significantly reduced in the animals 
pretreated with melatonin and subjected to acute pan-
creatitis[10,106,110,113,115-118]. In contrast, the blood level of  
anti-inflammatory IL-10 was increased markedly in these 
animals[10,116].
It is worth noting that the favorable effects of  mela-
tonin on acute pancreatitis were paralleled by its pre-
cursor, L-tryptophan. Application of  L-tryptophan to 
animals produced the significant and dose-dependent 
increase of  melatonin blood level. This observation indi-
cates that the anti-inflammatory effects of  L-tryptophan 
are probably dependent on the conversion of  this amino 
acid to melatonin. The above favorable effects of  mela-
tonin or L-tryptophan have been observed in rats sub-
jected to caerulein-induced pancreatitis as well as in those 
with pancreatitis induced by ischemia-reperfusion[108]. 
Nevertheless, the beneficial effects of  melatonin on 
acute pancreatitis have been demonstrated in different 
models of  pancreatic inflammation, such as L-arginine 
pancreatitis, pancreatitis induced by taurocholic acid, and 
by obstruction of  the pancreatic duct[110,117,119]. In severe 
acute pancreatitis, pretreatment with melatonin prevented 
multiorgan failure and significantly attenuated tissue dam-
age[119]. Melatonin has been shown to increase the nucleic 
acid content and rate of  DNA synthesis in the pancreas 
and thus to improve pancreatic regeneration in animals 
subjected to acute pancreatitis[120]. 
The mechanism of  the pancreatic protective action 
of  melatonin is complex. Melatonin works as a direct and 
indirect antioxidant and effectively reduced the amount 
of  lipid peroxidation products in pancreatic tissue, which 
is accompanied by the increase of  antioxidant enzymes, 
such as SOD or GPx[98,121]. Melatonin also slows down 
apoptosis and necrosis in the pancreas and turns down 
leukocyte infiltration in the pancreatic tissue subjected to 
acute inflammation. The blood levels of  pro-inflamma-
tory interleukin, such as TNFα, IL-1β, IL-6 and IL-22, 
were reduced, whereas anti-inflammatory IL-10 increased 
in response to melatonin application[10,105,116,119]. Among 
the other mechanisms of  the pancreatic protection af-
forded by melatonin is the improvement of  pancreatic 
blood flow, which ameliorates the tissues from the toxic 
inflammatory products and mediators[108,113]. Melatonin 
lowers the activity of  macrophages and decreases the 
production of  enzyme myeloperoxidase and generation 
of  prostaglandin[104,105]. Melatonin has also been shown to 
trigger the production of  heat shock protein 60 (HSP60) 
in the pancreatic acinar AR42J cells. Activation of  HSP60 
by melatonin could protect the intracellular structures 
against inflammatory damage and could reduce the acinar 
cell injury[122] (Figure 1).
Melatonin seems to be a part of  the natural protec-
tive mechanisms against the development of  pancreatic 
inflammation and low melatonin production is associ-
ated with an increased risk of  severe acute pancreati-
tis[118,123,124]. Recent reports indicate that the melatonin 
blood level in humans is closely related to the severity 
of  pancreatitis. It has been proposed that the evaluation 
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of  disease severity could be assessed by measuring the 
blood levels of  melatonin[125]. 
It is very likely that melatonin might be a part of  na-
tive protection against the development of  acute pancre-
atitis and a low melatonin blood level could be associated 
with an increased risk of  the severe form of  this disease. 
Perhaps melatonin could be used in the prevention of  
acute pancreatitis in individuals with an increased risk of  
pancreatic inflammation. 
CONCLUSION
Ghrelin, leptin and melatonin given prior to the induc-
tion of  experimental acute pancreatitis resulted in the 
significant attenuation of  pancreatitis severity and pro-
tected pancreatic tissue against inflammatory damage. 
The mechanisms of  the beneficial influence of  the above 
substances are related to the mobilization of  non-specific 
immune defense, to the inhibition of  nuclear NF-κB and 
the modulation of  cytokine production, to the stimula-
tion of  heat shock protein, as well as to the activation of  
the antioxidant system. Experimental and clinical data 
have shown that blood levels of  ghrelin, leptin and mela-
tonin increase in the initial phase of  pancreatic inflam-
mation. This observation indicates that these hormones 
could be a part of  the innate resistance system which 
might remove noxious factors and could suppress or at-
tenuate the inflammatory process in the pancreas. 
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